Compare AbbVie Inc (ABBV) vs Amazon.com Inc (AMZN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs Amazon.com Inc — how do they compare? AbbVie Inc trades at $248.48 (market cap $441.94B), while Amazon.com Inc trades at $273.35 (market cap $2.94T). The key difference: Amazon.com Inc is far larger — about 6.7× AbbVie Inc's market cap, and AbbVie Inc pays a 2.77% dividend while Amazon.com Inc pays none. Which is the better fit depends on your goals.
| ABBV | AMZN | |
|---|---|---|
Market Cap | $441.94B | $2.94T |
Sector | Health | Consumer Cyclical |
52-Week High | $263.58 | $284.02 |
52-Week Low | $197.38 | $198.79 |
Enterprise Value | $506.19B | $3.04T |
Dividend Yield | 2.77% | — |
Volume | — | 3,931,282 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $247.91, up 0.76% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 70.73% buy consensus highlight robust fundamentals, driven by Skyrizi and Rinvoq growth offsetting Humira declines. Positive news includes Phase 2 ovarian cancer data and institutional stake increases, reinforcing momentum.
Outlook remains positive with a $278.69 price target, though risks include patent cliffs and debt levels. Revenue growth and dividend stability offer appeal, but investors should monitor competitive pressures and regulatory developments for sustained performance.
Amazon (AMZN) trades at $278.09, up 1.32% with strong bullish momentum as technical indicators show the stock above key support levels. The company demonstrates robust fundamentals with revenue growing to $716.92 billion in 2025 and net income reaching $77.67 billion, representing a 10.83% margin. Recent earnings beats in Q1 and Q2 2026 exceeded expectations significantly, while analyst sentiment remains overwhelmingly positive with 89% buy ratings.
Amazon's outlook remains favorable with continued revenue growth projected to $775.7 billion in 2026 and expanding profit margins. The primary investment opportunity lies in AWS growth and AI chip development, though risks include intense competition in e-commerce and significant capital expenditures. With a consensus price target of $333.86 representing 20% upside potential, the stock appears positioned for continued growth despite near-term overbought technical conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Amazon.com Inc
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →
